A clinical trial to study the effects of two drugs, Manjishthadi tailam & Manjishthadi cream in Melasma.
Phase 2
- Conditions
- Health Condition 1: L819- Disorder of pigmentation, unspecified
- Registration Number
- CTRI/2023/05/052826
- Lead Sponsor
- ilam Pravin Chavan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having Age between 20-60 years of any gender.
Patients having cardinal symptoms of vyanga like niruja , tanu , shyava
mandal over face , chronicity less than 5 years.
All the three clinical presentations that is 1)
Central facial pattern 2) Malar
Pattern 3)Mandibular Pattern. Will be included in the study.
Patients who are willing to participate in the study.
Exclusion Criteria
Hyperpigmentation caused due to any systemic illness such as Addisonâ??s
disease , systemic lupus erythematous.
Hyperpigmentation caused by malignant melanoma.
Pregnant and lactating females.
Patients having congenital hyperpigmentation like nevus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There will be change in skin colour, Hyperpigmentation will get reduced. So that manjishthadi tail and cream effective in melasma.Timepoint: 3 month
- Secondary Outcome Measures
Name Time Method 1. To study the changes in MASI (MELASMA AREA SEVERITY INDEX) <br/ ><br>SCORE, In the area of involvement and pigmentation in Vyanga. <br/ ><br>2. To study the changes in skin texture. <br/ ><br>3. To assess recurrence after completion of treatment after a gap of 1 month <br/ ><br>without treatment. <br/ ><br>4. To observe Adverse drug reaction takes place during study (If any).Timepoint: 4 months